Detection of Carbapenemase Production in Klebsiella pneumoniaeIsolates by Rapid Carbapenemase Detection Method in an OXA-48Endemic Region

被引:0
作者
Cizmeci, Zeynep [1 ]
机构
[1] Univ Hlth Sci, Bakirkoy Dr Sadi Konuk Training & Res Hosp, Dept Med Microbiol, Istanbul, Turkiye
关键词
Carbapenem-Resistant Klebsiella pneumoniae; Modified Carbapenem Inactivation Method (mCIM); RapidCarbapenemase Detection Method (rCDM); RESISTANCE;
D O I
10.5812/jjm-146081
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Background: Carbapenem resistance is one of the major global public health threats caused by the overuse or misuse ofcarbapenems, which are often the last resort in treating multidrug-resistant infections. Today, timely detection ofcarbapenemase-producing organisms is critical for infection control. Therefore, rapid and accurate detection ofcarbapenemases using a cost-effective method with high sensitivity and specificity is essential to guide appropriate treatmentand prevent further spread.Objectives: This study aimed to evaluate the sensitivity of the newly developed rapid carbapenemase detection method (rCDM)with isolates whose resistance genes were determined by molecular methods and to compare it with the modified carbapeneminactivation method (mCIM), whose diagnostic performance characteristics are well-defined.Methods: A total of 130 Klebsiella pneumoniae isolates (65 carbapenem-susceptible, 65 carbapenem-resistant) from variousclinical specimens were included in the study. Identification and antibiotic susceptibility testing of the isolates was performedusing the BD Phoenix (TM) automated system. Phenotypic carbapenemase detection methods, mCIM and rCDM, were studied for allcarbapenem-sensitive and carbapenem-resistant isolates with known resistance genes.Results: Among carbapenem-resistant K. pneumoniae isolates, blaOXA-48 was the most frequently detected resistance gene (78%).Using PCR results as the reference method, the sensitivity of rCDM was 100%. When rCDM and mCIM results were compared,both phenotypic methods were 100% compatible, with no statistically significant difference observed.Conclusions: Rapid carbapenemase detection method is a rapid and reliable phenotypic carbapenemase detection methodwith high sensitivity. Its ease of use and interpretation make it suitable for use in laboratories with limited resources.Additionally, its excellent performance in detecting common carbapenemase types and high consistency with mCIM support itsutility in various laboratory settings without requiring additional materials or technical infrastructure.
引用
收藏
页数:9
相关论文
共 28 条
  • [1] [Anonymous], 2019, Antimicrobial resistance
  • [2] OXA-48-Like β-Lactamases: Global Epidemiology, Treatment Options, and Development Pipeline
    Boyd, Sara E.
    Holmes, Alison
    Peck, Richard
    Livermore, David M.
    Hope, William
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2022, 66 (08)
  • [3] Phenotypic detection of carbapenemase production in carbapenem-resistant isolates with the rapid carbapenemase detection method (rCDM)
    Calik, Seyma
    Kansak, Nilgun
    Aksaray, Sebahat
    [J]. JOURNAL OF MICROBIOLOGICAL METHODS, 2022, 200
  • [4] A Review of Carbapenem Resistance in Enterobacterales and Its Detection Techniques
    Caliskan-Aydogan, Oznur
    Alocilja, Evangelyn C.
    [J]. MICROORGANISMS, 2023, 11 (06)
  • [5] Centers for Disease Control and Prevention, 2015, FAQs about choosing andimplementing a CRE definition
  • [6] Molecular characterization of carbapenem-resistant Enterobacteriaceae yields increasing rates of NDM-1 carbapenemases and colistin resistance in an OXA-48-endemic area
    Cizmeci, Zeynep
    Aktas, Elif
    Otlu, Baris
    Acikgoz, Ozlem
    Ordekci, Seyhan
    [J]. JOURNAL OF CHEMOTHERAPY, 2017, 29 (06) : 344 - 350
  • [7] CLSI, 2022, CLSI M100, VM100
  • [8] Impact of CLSI and EUCAST breakpoint discrepancies on reporting of antimicrobial susceptibility and AMR surveillance
    Cusack, T. P.
    Ashley, E. A.
    Ling, C. L.
    Rattanavong, S.
    Roberts, T.
    Turner, P.
    Wangrangsimakul, T.
    Dance, D. A. B.
    [J]. CLINICAL MICROBIOLOGY AND INFECTION, 2019, 25 (07) : 910 - 911
  • [10] EuropeanCommitteeonAntimicrobialSusceptibilityTesting, 2017, European Committee on Antimicrobial Susceptibility Testing Guidelinesfor detection of resistance mechanisms and specific resistances of clinicaland/or epidemiological importance, Version 2.0